Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders

The purpose of this notice is to advise stakeholders that Health Canada is proposing to: maintain the flexibilities and regulatory oversight provided by the Interim order respecting clinical trials for medical devices and drugs relating to COVID-19 until at least the fall of 2021, and bring forward regulatory amendments that would allow the flexibilities under the Interim Order to continue after the fall of 2021

Data and Resources

Additional Info

Field	Value
Last Updated	April 17, 2026, 17:46 (UTC)
Created	April 17, 2026, 17:46 (UTC)
criticality_level	[]
geographic_scope	[]
open_canada_collection	publication
open_canada_date_published	2021-01-21 00:00:00
open_canada_keywords	{"fr": ["assurer la prévisibilité", "essais cliniques sur la COVID-19", "proposition d'essais cliniques", "avis aux parties prenantes"], "en": ["ensuring predictability", "COVID-19 clinical trials", "proposal for clinical-trials", "notice to stakeholders"]}
open_canada_subject	["health_and_safety"]
sensitivity_level	unrestricted
title_fr	Garantir la prévisibilité des essais cliniques relatifs à la COVID-19 et proposition concernant la conservation des registres d’essais cliniques : Avis aux intervenants
update_frequency	as_needed